Selepressin
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
1-({(4R,7S,10S,13S,16S,19R)-19-Amino-10-(4-amino-4-oxobutyl)-7-(2-amino-2-oxoethyl)-16-benzyl-13-[(2S)-2-butanyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-N5-isopropyl-L-ornithylglycinamide
|
|
Identifiers | |
CAS Number | 876296-47-8 |
ATC code | None |
PubChem | CID: 53330936 |
ChemSpider | 26609297 |
Chemical data | |
Formula | C46H73N13O11S2 |
Molecular mass | 1048.282 g/mol |
|
|
|
Selepressin (INN) (code name FE-202158), also known as [Phe(2),Ile(3), Hgn(4),Orn(iPr)(8)]vasopressin) is a potent, highly selective, short-acting peptide full agonist of the vasopressin 1A receptor and analog of vasopressin which is under development by Ferring Pharmaceuticals for the treatment of vasodilatory hypotension in septic shock.[1][2][3][4]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Peptides
- Vasopressin receptor agonists
- Systemic hormonal preparation stubs